Compile Data Set for Download or QSAR
Report error Found 44 Enz. Inhib. hit(s) with all data for entry = 1552
TargetCystathionine gamma-lyase(Human)
Sova Pharmaceuticals

US Patent
LigandPNGBDBM330309(US9725426, 13)
Affinity DataIC50: 1.00E+4nMAssay Description:Test compounds (from DMSO stock solutions) were added to (final concentrations) 20 ug/ml enzyme solution (human, mouse or rat recombinant CSE) plus 5...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/12/2019
Entry Details
Go to US Patent

TargetCystathionine gamma-lyase(Human)
Sova Pharmaceuticals

US Patent
LigandPNGBDBM330320(US9725426, 24)
Affinity DataIC50: 1.00E+4nMAssay Description:Test compounds (from DMSO stock solutions) were added to (final concentrations) 20 ug/ml enzyme solution (human, mouse or rat recombinant CSE) plus 5...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/12/2019
Entry Details
Go to US Patent

TargetCystathionine gamma-lyase(Human)
Sova Pharmaceuticals

US Patent
LigandPNGBDBM330319(US9725426, 23)
Affinity DataIC50: 1.00E+4nMAssay Description:Test compounds (from DMSO stock solutions) were added to (final concentrations) 20 ug/ml enzyme solution (human, mouse or rat recombinant CSE) plus 5...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/12/2019
Entry Details
Go to US Patent

TargetCystathionine gamma-lyase(Human)
Sova Pharmaceuticals

US Patent
LigandPNGBDBM330318(US9725426, 22)
Affinity DataIC50: 1.00E+4nMAssay Description:Test compounds (from DMSO stock solutions) were added to (final concentrations) 20 ug/ml enzyme solution (human, mouse or rat recombinant CSE) plus 5...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/12/2019
Entry Details
Go to US Patent

TargetCystathionine gamma-lyase(Human)
Sova Pharmaceuticals

US Patent
LigandPNGBDBM330317(US9725426, 21)
Affinity DataIC50: 1.00E+4nMAssay Description:Test compounds (from DMSO stock solutions) were added to (final concentrations) 20 ug/ml enzyme solution (human, mouse or rat recombinant CSE) plus 5...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/12/2019
Entry Details
Go to US Patent

TargetCystathionine gamma-lyase(Human)
Sova Pharmaceuticals

US Patent
LigandPNGBDBM330316(US9725426, 20)
Affinity DataIC50: 1.00E+4nMAssay Description:Test compounds (from DMSO stock solutions) were added to (final concentrations) 20 ug/ml enzyme solution (human, mouse or rat recombinant CSE) plus 5...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/12/2019
Entry Details
Go to US Patent

TargetCystathionine gamma-lyase(Human)
Sova Pharmaceuticals

US Patent
LigandPNGBDBM330321(US9725426, 25)
Affinity DataIC50: 1.00E+4nMAssay Description:Test compounds (from DMSO stock solutions) were added to (final concentrations) 20 ug/ml enzyme solution (human, mouse or rat recombinant CSE) plus 5...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/12/2019
Entry Details
Go to US Patent

TargetCystathionine gamma-lyase(Human)
Sova Pharmaceuticals

US Patent
LigandPNGBDBM330322(US9725426, 26)
Affinity DataIC50: 1.00E+4nMAssay Description:Test compounds (from DMSO stock solutions) were added to (final concentrations) 20 ug/ml enzyme solution (human, mouse or rat recombinant CSE) plus 5...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/12/2019
Entry Details
Go to US Patent

TargetCystathionine gamma-lyase(Human)
Sova Pharmaceuticals

US Patent
LigandPNGBDBM330324(US9725426, 28)
Affinity DataIC50: 1.00E+4nMAssay Description:Test compounds (from DMSO stock solutions) were added to (final concentrations) 20 ug/ml enzyme solution (human, mouse or rat recombinant CSE) plus 5...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/12/2019
Entry Details
Go to US Patent

TargetCystathionine gamma-lyase(Human)
Sova Pharmaceuticals

US Patent
LigandPNGBDBM330311(US9725426, 15)
Affinity DataIC50: 1.00E+4nMAssay Description:Test compounds (from DMSO stock solutions) were added to (final concentrations) 20 ug/ml enzyme solution (human, mouse or rat recombinant CSE) plus 5...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/12/2019
Entry Details
Go to US Patent

TargetCystathionine gamma-lyase(Human)
Sova Pharmaceuticals

US Patent
LigandPNGBDBM330308(US9725426, 12)
Affinity DataIC50: 1.00E+4nMAssay Description:Test compounds (from DMSO stock solutions) were added to (final concentrations) 20 ug/ml enzyme solution (human, mouse or rat recombinant CSE) plus 5...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/12/2019
Entry Details
Go to US Patent

TargetCystathionine gamma-lyase(Human)
Sova Pharmaceuticals

US Patent
LigandPNGBDBM330307(US9725426, 11)
Affinity DataIC50: 1.00E+4nMAssay Description:Test compounds (from DMSO stock solutions) were added to (final concentrations) 20 ug/ml enzyme solution (human, mouse or rat recombinant CSE) plus 5...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/12/2019
Entry Details
Go to US Patent

TargetCystathionine gamma-lyase(Human)
Sova Pharmaceuticals

US Patent
LigandPNGBDBM330331(US9725426, 2-hydrazinylacetic acid)
Affinity DataIC50: 1.00E+4nMAssay Description:Test compounds (from DMSO stock solutions) were added to (final concentrations) 20 ug/ml enzyme solution (human, mouse or rat recombinant CSE) plus 5...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/12/2019
Entry Details
Go to US Patent

TargetCystathionine gamma-lyase(Human)
Sova Pharmaceuticals

US Patent
LigandPNGBDBM330339(US9725426, (E)-5-(2-(furan-2-ylmethylene)hydraziny...)
Affinity DataIC50: 1.00E+4nMAssay Description:Test compounds (from DMSO stock solutions) were added to (final concentrations) 20 ug/ml enzyme solution (human, mouse or rat recombinant CSE) plus 5...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/12/2019
Entry Details
Go to US Patent

TargetCystathionine gamma-lyase(Human)
Sova Pharmaceuticals

US Patent
LigandPNGBDBM330300(US9725426, 4)
Affinity DataIC50: 1.00E+4nMAssay Description:Test compounds (from DMSO stock solutions) were added to (final concentrations) 20 ug/ml enzyme solution (human, mouse or rat recombinant CSE) plus 5...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/12/2019
Entry Details
Go to US Patent

TargetCystathionine gamma-lyase(Human)
Sova Pharmaceuticals

US Patent
LigandPNGBDBM330299(US9725426, 3)
Affinity DataIC50: 1.00E+4nMAssay Description:Test compounds (from DMSO stock solutions) were added to (final concentrations) 20 ug/ml enzyme solution (human, mouse or rat recombinant CSE) plus 5...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/12/2019
Entry Details
Go to US Patent

TargetCystathionine gamma-lyase(Human)
Sova Pharmaceuticals

US Patent
LigandPNGBDBM330340(US9725426, 5-hydrazinyl-1H-tetrazole)
Affinity DataIC50: 5.50E+4nMAssay Description:Test compounds (from DMSO stock solutions) were added to (final concentrations) 20 ug/ml enzyme solution (human, mouse or rat recombinant CSE) plus 5...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/12/2019
Entry Details
Go to US Patent

TargetCystathionine gamma-lyase(Human)
Sova Pharmaceuticals

US Patent
LigandPNGBDBM330327(US9725426, 32)
Affinity DataIC50: 5.50E+4nMAssay Description:Test compounds (from DMSO stock solutions) were added to (final concentrations) 20 ug/ml enzyme solution (human, mouse or rat recombinant CSE) plus 5...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/12/2019
Entry Details
Go to US Patent

TargetCystathionine gamma-lyase(Human)
Sova Pharmaceuticals

US Patent
LigandPNGBDBM330332(US9725426, 2-(2-(propan-2-ylidene)hydrazinyl)aceti...)
Affinity DataIC50: 5.50E+4nMAssay Description:Test compounds (from DMSO stock solutions) were added to (final concentrations) 20 ug/ml enzyme solution (human, mouse or rat recombinant CSE) plus 5...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/12/2019
Entry Details
Go to US Patent

TargetCystathionine gamma-lyase(Human)
Sova Pharmaceuticals

US Patent
LigandPNGBDBM330323(US9725426, 27)
Affinity DataIC50: 5.50E+4nMAssay Description:Test compounds (from DMSO stock solutions) were added to (final concentrations) 20 ug/ml enzyme solution (human, mouse or rat recombinant CSE) plus 5...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/12/2019
Entry Details
Go to US Patent

TargetCystathionine gamma-lyase(Human)
Sova Pharmaceuticals

US Patent
LigandPNGBDBM330333(US9725426, 4-((2-(1H-tetrazol-5-yl)hydrazinyl)meth...)
Affinity DataIC50: 5.50E+4nMAssay Description:Test compounds (from DMSO stock solutions) were added to (final concentrations) 20 ug/ml enzyme solution (human, mouse or rat recombinant CSE) plus 5...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/12/2019
Entry Details
Go to US Patent

TargetCystathionine gamma-lyase(Human)
Sova Pharmaceuticals

US Patent
LigandPNGBDBM330334(US9725426, (E)-4-((2-(1H-tetrazol-5-yl)hydrazono)m...)
Affinity DataIC50: 5.50E+4nMAssay Description:Test compounds (from DMSO stock solutions) were added to (final concentrations) 20 ug/ml enzyme solution (human, mouse or rat recombinant CSE) plus 5...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/12/2019
Entry Details
Go to US Patent

TargetCystathionine gamma-lyase(Human)
Sova Pharmaceuticals

US Patent
LigandPNGBDBM330337(US9725426, (E)-4-((2-(1H-tetrazol-5-yl)hydrazono)m...)
Affinity DataIC50: 5.50E+4nMAssay Description:Test compounds (from DMSO stock solutions) were added to (final concentrations) 20 ug/ml enzyme solution (human, mouse or rat recombinant CSE) plus 5...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/12/2019
Entry Details
Go to US Patent

TargetCystathionine gamma-lyase(Human)
Sova Pharmaceuticals

US Patent
LigandPNGBDBM330297(US9725426, 1)
Affinity DataIC50: 5.50E+4nMAssay Description:Test compounds (from DMSO stock solutions) were added to (final concentrations) 20 ug/ml enzyme solution (human, mouse or rat recombinant CSE) plus 5...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/12/2019
Entry Details
Go to US Patent

TargetCystathionine gamma-lyase(Human)
Sova Pharmaceuticals

US Patent
LigandPNGBDBM330314(US9725426, 18)
Affinity DataIC50: 5.50E+4nMAssay Description:Test compounds (from DMSO stock solutions) were added to (final concentrations) 20 ug/ml enzyme solution (human, mouse or rat recombinant CSE) plus 5...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/12/2019
Entry Details
Go to US Patent

TargetCystathionine gamma-lyase(Human)
Sova Pharmaceuticals

US Patent
LigandPNGBDBM330313(US9725426, 17)
Affinity DataIC50: 5.50E+4nMAssay Description:Test compounds (from DMSO stock solutions) were added to (final concentrations) 20 ug/ml enzyme solution (human, mouse or rat recombinant CSE) plus 5...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/12/2019
Entry Details
Go to US Patent

TargetCystathionine gamma-lyase(Human)
Sova Pharmaceuticals

US Patent
LigandPNGBDBM330312(US9725426, 16)
Affinity DataIC50: 5.50E+4nMAssay Description:Test compounds (from DMSO stock solutions) were added to (final concentrations) 20 ug/ml enzyme solution (human, mouse or rat recombinant CSE) plus 5...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/12/2019
Entry Details
Go to US Patent

TargetCystathionine gamma-lyase(Human)
Sova Pharmaceuticals

US Patent
LigandPNGBDBM330310(US9725426, 14)
Affinity DataIC50: 5.50E+4nMAssay Description:Test compounds (from DMSO stock solutions) were added to (final concentrations) 20 ug/ml enzyme solution (human, mouse or rat recombinant CSE) plus 5...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/12/2019
Entry Details
Go to US Patent

TargetCystathionine gamma-lyase(Human)
Sova Pharmaceuticals

US Patent
LigandPNGBDBM330302(US9725426, 6)
Affinity DataIC50: 5.50E+4nMAssay Description:Test compounds (from DMSO stock solutions) were added to (final concentrations) 20 ug/ml enzyme solution (human, mouse or rat recombinant CSE) plus 5...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/12/2019
Entry Details
Go to US Patent

TargetCystathionine gamma-lyase(Human)
Sova Pharmaceuticals

US Patent
LigandPNGBDBM330303(US9725426, 7)
Affinity DataIC50: 5.50E+4nMAssay Description:Test compounds (from DMSO stock solutions) were added to (final concentrations) 20 ug/ml enzyme solution (human, mouse or rat recombinant CSE) plus 5...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/12/2019
Entry Details
Go to US Patent

TargetCystathionine gamma-lyase(Human)
Sova Pharmaceuticals

US Patent
LigandPNGBDBM330298(US9725426, 2)
Affinity DataIC50: 1.00E+5nMAssay Description:Test compounds (from DMSO stock solutions) were added to (final concentrations) 20 ug/ml enzyme solution (human, mouse or rat recombinant CSE) plus 5...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/12/2019
Entry Details
Go to US Patent

TargetCystathionine gamma-lyase(Human)
Sova Pharmaceuticals

US Patent
LigandPNGBDBM330315(US9725426, 19)
Affinity DataIC50: 1.00E+5nMAssay Description:Test compounds (from DMSO stock solutions) were added to (final concentrations) 20 ug/ml enzyme solution (human, mouse or rat recombinant CSE) plus 5...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/12/2019
Entry Details
Go to US Patent

TargetCystathionine gamma-lyase(Human)
Sova Pharmaceuticals

US Patent
LigandPNGBDBM330301(US9725426, 5)
Affinity DataIC50: 1.00E+5nMAssay Description:Test compounds (from DMSO stock solutions) were added to (final concentrations) 20 ug/ml enzyme solution (human, mouse or rat recombinant CSE) plus 5...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/12/2019
Entry Details
Go to US Patent

TargetCystathionine gamma-lyase(Human)
Sova Pharmaceuticals

US Patent
LigandPNGBDBM330338(US9725426, (E)-5-(2-(4-nitrobenzylidene)hydrazinyl...)
Affinity DataIC50: 1.00E+5nMAssay Description:Test compounds (from DMSO stock solutions) were added to (final concentrations) 20 ug/ml enzyme solution (human, mouse or rat recombinant CSE) plus 5...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/12/2019
Entry Details
Go to US Patent

TargetCystathionine gamma-lyase(Human)
Sova Pharmaceuticals

US Patent
LigandPNGBDBM330336(US9725426, (E)-5-(2-(benzo[d][1,3]dioxol-5-ylmethy...)
Affinity DataIC50: 1.00E+5nMAssay Description:Test compounds (from DMSO stock solutions) were added to (final concentrations) 20 ug/ml enzyme solution (human, mouse or rat recombinant CSE) plus 5...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/12/2019
Entry Details
Go to US Patent

TargetCystathionine gamma-lyase(Human)
Sova Pharmaceuticals

US Patent
LigandPNGBDBM330335(US9725426, (E)-1-((2-(1H-tetrazol-5-yl)hydrazono)m...)
Affinity DataIC50: 1.00E+5nMAssay Description:Test compounds (from DMSO stock solutions) were added to (final concentrations) 20 ug/ml enzyme solution (human, mouse or rat recombinant CSE) plus 5...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/12/2019
Entry Details
Go to US Patent

TargetCystathionine gamma-lyase(Human)
Sova Pharmaceuticals

US Patent
LigandPNGBDBM330304(US9725426, 8)
Affinity DataIC50: 1.00E+5nMAssay Description:Test compounds (from DMSO stock solutions) were added to (final concentrations) 20 ug/ml enzyme solution (human, mouse or rat recombinant CSE) plus 5...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/12/2019
Entry Details
Go to US Patent

TargetCystathionine gamma-lyase(Human)
Sova Pharmaceuticals

US Patent
LigandPNGBDBM330305(US9725426, 9)
Affinity DataIC50: 1.00E+5nMAssay Description:Test compounds (from DMSO stock solutions) were added to (final concentrations) 20 ug/ml enzyme solution (human, mouse or rat recombinant CSE) plus 5...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/12/2019
Entry Details
Go to US Patent

TargetCystathionine gamma-lyase(Human)
Sova Pharmaceuticals

US Patent
LigandPNGBDBM330306(US9725426, 10)
Affinity DataIC50: 1.00E+5nMAssay Description:Test compounds (from DMSO stock solutions) were added to (final concentrations) 20 ug/ml enzyme solution (human, mouse or rat recombinant CSE) plus 5...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/12/2019
Entry Details
Go to US Patent

TargetCystathionine gamma-lyase(Human)
Sova Pharmaceuticals

US Patent
LigandPNGBDBM330330(US9725426, 35)
Affinity DataIC50: 1.00E+5nMAssay Description:Test compounds (from DMSO stock solutions) were added to (final concentrations) 20 ug/ml enzyme solution (human, mouse or rat recombinant CSE) plus 5...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/12/2019
Entry Details
Go to US Patent

TargetCystathionine gamma-lyase(Human)
Sova Pharmaceuticals

US Patent
LigandPNGBDBM330329(US9725426, 34)
Affinity DataIC50: 1.00E+5nMAssay Description:Test compounds (from DMSO stock solutions) were added to (final concentrations) 20 ug/ml enzyme solution (human, mouse or rat recombinant CSE) plus 5...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/12/2019
Entry Details
Go to US Patent

TargetCystathionine gamma-lyase(Human)
Sova Pharmaceuticals

US Patent
LigandPNGBDBM330328(US9725426, 33)
Affinity DataIC50: 1.00E+5nMAssay Description:Test compounds (from DMSO stock solutions) were added to (final concentrations) 20 ug/ml enzyme solution (human, mouse or rat recombinant CSE) plus 5...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/12/2019
Entry Details
Go to US Patent

TargetCystathionine gamma-lyase(Human)
Sova Pharmaceuticals

US Patent
LigandPNGBDBM330326(US9725426, 31)
Affinity DataIC50: 1.00E+5nMAssay Description:Test compounds (from DMSO stock solutions) were added to (final concentrations) 20 ug/ml enzyme solution (human, mouse or rat recombinant CSE) plus 5...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/12/2019
Entry Details
Go to US Patent

TargetCystathionine gamma-lyase(Human)
Sova Pharmaceuticals

US Patent
LigandPNGBDBM330325(US9725426, 29)
Affinity DataIC50: 1.00E+5nMAssay Description:Test compounds (from DMSO stock solutions) were added to (final concentrations) 20 ug/ml enzyme solution (human, mouse or rat recombinant CSE) plus 5...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/12/2019
Entry Details
Go to US Patent